PROLATE

This brand name is authorized in United States

Active ingredients

The drug PROLATE contains a combination of these active pharmaceutical ingredients (APIs):

1 Oxycodone UNII C1ENJ2TE6C - OXYCODONE HYDROCHLORIDE

Oxycodone is a full opioid agonist with no antagonist properties. It has an affinity for kappa, mu and delta opioid receptors in the brain and spinal cord. Oxycodone is similar to morphine in its action. The therapeutic effect is mainly analgesic, anxiolytic, antitussive and sedative. Read about Oxycodone

2 Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN

Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain. Read about Paracetamol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
PROLATE Oral solution	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02AJ17		N Nervous system → N02 Analgesics → N02A Opioids → N02AJ Opioids in combination with non-opioid analgesics
Discover more medicines within N02AJ17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 72245-648, 72245-681, 72245-682, 72245-683